Albert Schatz

Albert Schatz was an American microbiologist who made significant contributions to the field of Microbiology at Rutgers University, particularly in the discovery of Streptomycin, a crucial antibiotic used to treat Tuberculosis. His work, in collaboration with Selman Waksman and H. Christine Reilly, led to the development of Streptomycin as a treatment for Tuberculosis, a disease that had been prevalent and often fatal, as seen in the cases of Frédéric Chopin and Robert Louis Stevenson. Schatz's discovery was a major breakthrough in the fight against Tuberculosis, and it paved the way for the development of other Antibiotics, such as Penicillin and Tetracycline, by researchers like Alexander Fleming and Howard Florey at University of Oxford and University of Cambridge.

● Early Life and Education

Albert Schatz was born on February 2, 1920, in Norwich, Connecticut, to a family of modest means, and he developed an interest in Microbiology and Biochemistry at an early age, inspired by the work of scientists like Louis Pasteur and Robert Koch at Institut Pasteur and University of Berlin. He pursued his undergraduate degree at Rutgers University, where he was introduced to the field of Microbiology by prominent researchers like Selman Waksman and René Dubos at Rutgers University and Rockefeller University. Schatz's academic excellence earned him a graduate scholarship to study at University of California, Berkeley, where he worked under the guidance of renowned scientists like William Hayes and Joshua Lederberg at University of California, Berkeley and University of Wisconsin–Madison.

● Career

Schatz's career in Microbiology began at Rutgers University, where he worked as a research assistant to Selman Waksman, a prominent scientist in the field of Antibiotics and Microbiology at Rutgers University and New Jersey Agricultural Experiment Station. During his time at Rutgers University, Schatz was involved in the discovery of several Antibiotics, including Streptomycin, which was isolated from the soil bacterium Streptomyces griseus found in the New Jersey Agricultural Experiment Station and Soil Microbiology Laboratory. Schatz's work on Streptomycin led to its development as a treatment for Tuberculosis, and it paved the way for the discovery of other Antibiotics by researchers like George Merck and Henry Welch at Merck & Co. and National Institutes of Health.

● Discovery of Streptomycin

The discovery of Streptomycin by Schatz and Selman Waksman in 1943 was a major breakthrough in the fight against Tuberculosis, a disease that had been prevalent and often fatal, as seen in the cases of Frédéric Chopin and Robert Louis Stevenson at Hôpital de la Charité and British Lung Association. Streptomycin was the first antibiotic to be effective against Tuberculosis, and it revolutionized the treatment of the disease, as seen in the work of Edward Livingston Trudeau and Lawrence Flick at Adirondack Cottage Sanitarium and Henry Phipps Institute. The discovery of Streptomycin also led to the development of other Antibiotics, such as Isoniazid and Rifampicin, by researchers like Gerhard Domagk and Selman Waksman at Bayer and Rutgers University.

● Controversy and Legacy

Schatz's discovery of Streptomycin was not without controversy, as he was involved in a dispute with Selman Waksman over the ownership of the patent for the antibiotic, which was eventually resolved in favor of Rutgers University and Waksman at United States Patent and Trademark Office and New Jersey Court of Appeals. Despite the controversy, Schatz's contribution to the discovery of Streptomycin was recognized by the scientific community, and he was awarded the Squibb Award in 1947, along with Selman Waksman and H. Christine Reilly, for his work on Streptomycin at National Academy of Sciences and American Society for Microbiology. Schatz's legacy extends beyond his discovery of Streptomycin, as he continued to work on the development of new Antibiotics and Vaccines throughout his career, collaborating with researchers like Jonas Salk and Maurice Hilleman at University of Pittsburgh and Merck & Co..

● Personal Life

Schatz's personal life was marked by his dedication to his work and his family, as seen in the accounts of his colleagues and friends, including Selman Waksman and H. Christine Reilly at Rutgers University and American Society for Microbiology. He was married to his wife, Vivian Schatz, and had two children, Albert Schatz Jr. and Vivian Schatz Jr., who followed in his footsteps in the field of Microbiology and Biochemistry at Rutgers University and University of California, Berkeley. Schatz passed away on January 17, 2005, at the age of 84, leaving behind a legacy of contributions to the field of Microbiology and the development of Antibiotics, as recognized by institutions like National Institutes of Health and World Health Organization.

Category:American microbiologists